Synergistic apoptotic effect of arabinoxylan rice bran (MGN-3/Biobran) and curcumin (Turmeric) on human multiple myeloma cell line U266 in vitro

Neoplasma

Volumn 58, Issue 2, 2011, Pages 118-123

  Ghoneum, M ^a   Gollapudi, S ^b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer cell survival; Curcumin; MGN 3; Synergistic effect; U266

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARABINOXYLAN; PROTEIN BAX; PROTEIN BCL 2; TRYPAN BLUE; TURMERIC; ANTINEOPLASTIC AGENT; CURCUMIN; POLYSACCHARIDE MGN3; XYLAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL COUNT; CELL CYCLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MULTIPLE MYELOMA; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; DRUG EFFECT; DRUG POTENTIATION; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DRUG SYNERGISM; HUMANS; MULTIPLE MYELOMA; XYLANS;

EID: 79961106902     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_02_118     Document Type: Article

References (41)

1. HALLEK M, BERGSAGEL PL, ANDERSON KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91: 3-21.
2. Diagnosis and management of multiple myeloma: UK myeloma forum. British Committee for Standards in Haematology. Br J Haematol 2001; 115: 522-540. doi:10.1046/ j.1365-2141.2001.03206.x
3. Report: 1973-1989 Annual Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 1992.
4. FEINMAN R, KOURY J, THAMES M, BARLOGIE B, EP-STEIN J et al. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 1999; 93: 3044-3052.
5. HUANG MT, SMART RC, WONG CQ, CONNEY AH. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1988; 48: 5941-5946.
6. HUANG MT, LYSZ T, FERRARO T, ABIDI TF, LASKIN JD et al. Inhibitory effects of curcumin in vivo lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 1991; 51: 813-819.
7. KUTTAN G, KUMAR KB, GURUVAYOORAPPAN C, KUTTAN R. Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv Exp Med Biol 2007; 595: 173-84. doi:10.1007/978-0-387-46401-5_6
8. NOAMAN E, BADR EL-DIN N, BIBARS M, ABOU AA, GHONEUN M. Antioxidant potential by arabinoxylan rice bran, MGN-3/Biobran, represents a mechanism for its oncostatic effect against murine Solid Ehrlich Carcinoma. Cancer Letters 2008; 268: 348-359. doi:10.1016/j.canlet.2008.04.012
9. BADR EL-DIN N, NOAMAN E, GHONEUM M. In vivo tumor inhibitory effects of nutritional rice bran supplement MGN3/biobran on Ehrlich Carcinoma-bearing mice. Nutrition and Cancer 2008; 60: 235-244. doi:10.1080/01635580701627285
10. GHONEUM M. Anti-HIV activity in vitro of MGN-3, an activated arabinoxylan from rice bran. Biochem Bioph Res Comm 1998 a; 243: 25-29. doi:10.1006/bbrc.1997.8047
11. GHONEUM M. Enhancement of human natural killer cell activity by modified arabinoxylan from rice bran (MGN-3). Int J Immunother XIV 1998 b; 2: 89-99.
12. GHONEUM M, ABEDI S. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharmacy Pharmacol 2004; 56: 1581-1588. doi:10.1211/0022357044922
13. GHONEUM M, GOLLAPUDI S. Modified arabinoxylan rice bran (MGN-3/Biobran) sensitizes human T cell leukemia cells to death receptor (CD95)-induced apoptosis. Cancer Letters 2003; 20: 41-49. doi:10.1016/S0304-3835(03)00458-0
14. GOLLAPUDI S and GHONEUM M. MGN-3/Biobran, modified arabinoxylan from rice bran, sensitizes human breast cancer cells to chemotherapeutic agent, daunorubicin. Cancer Detect Prev 2008; 32: 1-6. doi:10.1016/j.cdp.2008.02.006
15. MOSSMAN T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983; 65: 55-63. doi:10.1016/ 0022-1759(83)90303-4
16. ZHENG M, EKMEKCIOGLU S, WALCH ET, TANG CH, GRIMM EA. Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res 2004; 14: 165-171. doi:10.1097/01.cmr.0000129374.76399.19
17. PARKA J, AYYAPPANE V, BAE EK. LEE C, KIM BS et al. Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. Molecular Oncology 2008; 2: 317-326. doi:10.1016/ j.molonc.2008.09.006
18. OLIVIER S, CLOSE P, CASTERMANS E, DE LEVAL L, TABRUYN S et al. Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-kB Inhibition and Gene Expression Signature. Molecular Pharmacology 2006; 69: 1615-1623. doi:10.1124/mol.105.020479
19. ADAMS J. Proteasome inhibition in cancer: Development of PS-341. Semin Oncol 2001; 28: 613-619. doi:10.1016/S00937754(01)90034-X
20. BARLOGIE B, ZANGARI M, SPENCER T, FASSAS A, ANAISSIE E et al. Thalidomide in the management of multiple myeloma. Semin Hematol 2001; 38: 250-259. doi:10.1016/ S0037-1963(01)90017-4
21. KUNCHANDY E, RAO MNA. Oxygen scavenging activity of curcumin. Int J Pharm 1990; 38: 239-240.
22. SUBRAMANIAN M, SREEJAYAN, RAO MNA, DEVASA-GAYAM TP, SINGH BB. Diminution of singlet oxygen induced DNA-damage by curcumin and related antioxidants. Mutat Res 1994; 311: 249-255. doi:10.1016/0027-5107(94)90183-X
23. SREEJAYAN, RAO MNA. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 1994; 46: 1013-1016.
24. NOAMAN E, BADR RL-DIN N, BIBARS M, ABOU MOS-SALLAM AA, GHONEUM M. Antioxidant potential by arabinoxylan rice bran, MGN-3/Biobran, represents a mechanism for its oncostatic effect against murine Solid Ehrlich carcinoma. Cancer Letters 2008; 268: 348-359. doi:10.1016/ j.canlet.2008.04.012
25. OLATAVI ZN, MILLIMAN CL, KORSMEYER SJ: Bcl-2 heterodimerizes in vivo with a conserved homologue BAX that accelerates cell death. Cell 1994, 74:609-19.
26. KUWANA T, NEWMEYER DD. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 2003; 15: 691-699. doi:10.1016/j.ceb.2003.10.004
27. FESTJENS N, VAN GURP M, VAN LOO G, SAELENS X, VANDENABEELE P. Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. Acta Haematol 2004; 111: 7-27. doi:10.1159/000074483
28. THOMADAKI H, SCORILAS A. Bcl-2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci 2006; 43: 1-67. doi:10.1080/ 10408360500295626
29. CHEN JC, LU KW, TSAI ML, HSU SC, KUO CL et al. Gypenosides induced G0/G1 arrest via CHk2 and apoptosis through endoplasmic reticulum stress and mitochondriadependent pathways in human tongue cancer SCC-4 cells. Oral Onc 2009; 45: 273-28. doi:10.1016/j.oraloncology.2008.05.012
30. KANG JH, LEE YY, YU BY, YANG BS, CHO KH et al. Adiponectin induces growth arrest and apoptosis of MDAMB-231 breast cancer cell. Archives of Pharm Res 2005; 28: 1263-1269. doi:10.1007/BF02978210
31. LIU JD, WANG YJ, CHEN CH, YU CF, CHEN LC et al. Molecular Mechanisms of G0/G1 Cell-Cycle Arrest and Apoptosis Induced by Terfenadine in Human Cancer Cells. Mol Carcinogen 2003; 37: 39-50. doi:10.1002/mc.10118
32. HUNG JY, YANG JY, TSAI YM, HUANG HW, HUANG MS. Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells. Clin Exp Pharm Phys 2008; 31: 995-1001.
33. SHISHODIA S, AMIN HM, LAI R, HUANG HW, HUANG MS. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation,induces G1/S arrest, suppresses proliferation, and inducesapoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005, 70: 700-13. doi:10.1016/j.bcp.2005.04.043
34. DAIWA PHARMACEUTICAL CO, LTD. BioBran rice bran arabinoxylan compound. http://www.daiwapharm.com/emd/product.html
35. TAZAWA, K. BioBran/MGN-3: Basic and clinical application to integrative medicine. Japan: Iyakushuppan Co. Publishers, 2003.
36. BHARTI AC, DONATO N, SINGH, AGGARWAL BB. Cur-cumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003; 101: 1053-62. doi:10.1182/blood-2002-05-1320
37. CHENG AL, LIN JK, HSU MM, SHEN TS, KO JY et al. Phase I chemoprevention clinical trial of curcumin [abstract]. Proc Am Soc Clin Oncol 1998; 17: 558.
38. GHONEUM M and MATSUURA M. Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/biobran). Int J Immunopathol Pharmacol 2004; 17: 283-292.
39. CHOLUJOVA D, JAKUBIKOVA D, SEDLAK J. BioBran-augmented maturation of human monocyte-derived dendritic cells. Neoplasma 2009; 2: 89-95. doi:10.4149/neo_2009_02_89
40. LISSONI P, MISSINA G, BRIVIO F, FUMAGALLI L, VIGORE L et al. Modulation of the anticancer immunity by natural agents: inhibition of T regulatory lymphocyte generation by arabinoxylan in patients with locally limited or metastatic solid tumors. Cancer Ther 2008; 6: 1011-1016.
41. JAGETIA GC, AGGARWAL BB. Spicing up of the immune system by curcumin. J Clin Immunol 2007; 27: 19-35. doi:10.1007/s10875-006-9066-7